Radiation Therapy

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


972 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | ...
In press
 
Very high-energy electron therapy as light-particle alternative to transmission proton FLASH therapy - An evaluation of dosimetric performances.
Böhlen T.T., Germond J.F., Desorgher L., Veres I., Bratel A., Landström E., Engwall E., Herrera F.G., Ozsahin E.M., Bourhis J. et al. Radiotherapy and oncology. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_825ACAC4F6E5]
 
Acute hypoxia does not alter tumor sensitivity to FLASH radiotherapy.
Leavitt R.J., Almeida A., Grilj V., Montay-Gruel P., Godfroid C., Petit B., Bailat C., Limoli C.L., Vozenin M.C. International journal of radiation oncology, biology, physics. Peer-reviewed.
[DOI][Pmid][serval:BIB_44E104806F28]
 
ASO Visual Abstract: Low-Dose Radiation Yields Lower Rates of Pathologic Response in Esophageal Cancer Patients
Mantziari Styliani, Teixeira Farinha Hugo, Messier Marguerite, Winiker Michael, Allemann Pierre, Ozsahin Esat Mahmut, Demartines Nicolas, Piessen Guillaume, Schäfer Markus Annals of Surgical Oncology. Peer-reviewed.
[DOI][serval:BIB_2C5C5ECF7923]
 
Infrared microspectroscopy to elucidate the underlying biomolecular mechanisms of FLASH radiotherapy.
Martínez-Rovira I., Montay-Gruel P., Petit B., Leavitt R., González-Vegas R., Froidevaux P., Juchaux M., Prezado Y., Yousef I., Vozenin M.C. Radiotherapy and oncology. Peer-reviewed.
[DOI][Pmid][serval:BIB_EB86CFA54E0B]
2024
 
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study
Christ Sebastian M., Alongi Filippo, Ricardi Umberto, Scorsetti Marta, Livi Lorenzo, Balermpas Panagiotis, Lievens Yolande, Braam Pètra, Jereczek-Fossa Barbara Alicja, Stellamans Karin et al., 2024/06. Radiotherapy and Oncology, 195 p. 110235. Peer-reviewed.
[DOI][Pmid][serval:BIB_9D470E62D475]
Comparison of volumetric modulated arc therapy and helical tomotherapy for prostate cancer using Pareto fronts.
Wüthrich D., Wang Z., Zeverino M., Bourhis J., Bochud F., Moeckli R., 2024/04. Medical physics, 51 (4) pp. 3010-3019. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_49E1CA979679]
 
Low-Dose Radiation Yields Lower Rates of Pathologic Response in Esophageal Cancer Patients.
Mantziari S., Farinha H.T., Messier M., Winiker M., Allemann P., Ozsahin E.M., Demartines N., Piessen G., Schäfer M., 2024/04. Annals of surgical oncology, 31 (4) pp. 2499-2508. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6E98F3F586ED]
 
Proposition de délinéation des volumes cibles anatomocliniques postopératoires de la tumeur primitive des cancers du sinus maxillaire et des cavités nasales [Proposal for the delineation of postoperative primary clinical target volumes in maxillary sinus and nasal cavity cancers]
Guillemin F., Blanchard P., Boisselier P., Brahimi Y., Calugaru V., Coutte A., Gillon P., Graff P., Liem X., Modesto A. et al., 2024/04. Cancer radiotherapie, 28 (2) pp. 218-227. Peer-reviewed.
[DOI][Pmid][serval:BIB_1A80814091A3]
Antitumor Effect by Either FLASH or Conventional Dose Rate Irradiation Involves Equivalent Immune Responses.
Almeida A., Godfroid C., Leavitt R.J., Montay-Gruel P., Petit B., Romero J., Ollivier J., Meziani L., Sprengers K., Paisley R. et al., 2024/03/15. International journal of radiation oncology, biology, physics, 118 (4) pp. 1110-1122. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E2E833E715DF]
Stereotactic Radiosurgery and Stereotactic Fractionated Radiotherapy in the Management of Brain Metastases.
Benkhaled S., Schiappacasse L., Awde A., Kinj R., 2024/03/08. Cancers, 16 (6). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DF704342F299]
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial.
Guigay J., Ortholan C., Vansteene D., Cupissol D., Even C., Kaminsky M.C., Sire C., Blot E., Debourdeau P., Bozec L. et al., 2024/03. The lancet. Healthy longevity, 5 (3) pp. e182-e193. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_167AAFE038E3]
 
Randomized phase II selection trial of FLASH and conventional radiotherapy for patients with localized cutaneous squamous cell carcinoma or basal cell carcinoma: A study protocol.
Kinj R., Gaide O., Jeanneret-Sozzi W., Dafni U., Viguet-Carrin S., Sagittario E., Kypriotou M., Chenal J., Duclos F., Hebeisen M. et al., 2024/03. Clinical and translational radiation oncology, 45 p. 100743. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A13C0D7F4DC1]
 
Stereotactic body radiation therapy for prostate cancer after surgical treatment of prostatic obstruction: Impact on urinary morbidity and mitigation strategies.
Huck C., Achard V., Maitre P., Murthy V., Zilli T., 2024/03. Clinical and translational radiation oncology, 45 p. 100709. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5542BE38F9B4]
Dosimetric and biologic intercomparison between electron and proton FLASH beams.
Almeida A., Togno M., Ballesteros-Zebadua P., Franco-Perez J., Geyer R., Schaefer R., Petit B., Grilj V., Meer D., Safai S. et al., 2024/01. Radiotherapy and oncology, 190 p. 109953. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_70503C801F82]
 
Establishment of a murine hepatocellular carcinoma model by hydrodynamic injection and characterization of the immune tumor microenvironment.
Repáraz D., Casares N., Fuentes A., Navarro F., 2024. pp. 79-97 dans Animal Models of Disease, part A, Elsevier.
[DOI][Pmid][serval:BIB_E4A8DB081B6E]
Impact of the Mean Cochlear Biologically Effective Dose on Hearing Preservation After Stereotactic Radiosurgery for Vestibular Schwannoma: A Retrospective Longitudinal Analysis.
Tuleasca C., Toma-Dasu I., Duroux S., George M., Maire R., Daniel R.T., Patin D., Schiappacasse L., Dasu A., Faouzi M. et al., 2024/01/01. Neurosurgery, 94 (1) pp. 174-182. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_91D8B7537F40]
 
Letter to the Editor: SMAC mimetics inhibit human T cell proliferation and fail to augment type 1 cytokine responses.
Bourhis J., Sun X.S., Tao Y., 2024. Cellular immunology, 395-396 p. 104772. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_988F5287887C]
 
Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses.
Limkin E., Blanchard P., Lacas B., Bourhis J., Parmar M., Licitra L., Le Q.T., Yom S.S., Fortpied C., Langendijk J. et al., 2024/01. Radiotherapy and oncology, 190 p. 110011. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3FB310A6F592]
2023
 
In Vivo Cardiac Diffusion Imaging Without Motion-Compensation Leads to Unreasonably High Diffusivity.
Moulin K., Stoeck C.T., Axel L., Broncano J., Croisille P., Dall'Armellina E., Ennis D.B., Ferreira P.F., Gotschy A., Miro S. et al., 2023/12. Journal of magnetic resonance imaging, 58 (6) pp. 1990-1991. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AFA18A789F96]
 
Letter to the editor of radiotherapy and oncology regarding the paper "Stereotactic radiosurgery versus whole-brain radiotherapy in patients with 4-10 brain metastases: A nonrandomized controlled trial » by Bodensohn et al.
Benkhaled S., Collen C., Jullian N., 2023/12. Radiotherapy and oncology, 189 p. 109850. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_63FB7EA55727]
 
Refining critical structure contouring in STereotactic Arrhythmia Radioablation (STAR): Benchmark results and consensus guidelines from the STOPSTORM.eu consortium.
Balgobind B.V., Visser J., Grehn M., Marquard Knap M., de Ruysscher D., Levis M., Alcantara P., Boda-Heggemann J., Both M., Cozzi S. et al., 2023/12. Radiotherapy and oncology, 189 p. 109949. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EF6702A9B395]
 
The DRESDEN PLATFORM is a research hub for ultra-high dose rate radiobiology.
Metzkes-Ng J., Brack F.E., Kroll F., Bernert C., Bock S., Bodenstein E., Brand M., Cowan T.E., Gebhardt R., Hans S. et al., 2023/11/23. Scientific reports, 13 (1) p. 20611. Peer-reviewed.
[DOI][Pmid][serval:BIB_9E1465FE1727]
 
Effect of Conventional and Ultrahigh Dose Rate FLASH Irradiations on Preclinical Tumor Models: A Systematic Analysis.
Böhlen T.T., Germond J.F., Petersson K., Ozsahin E.M., Herrera F.G., Bailat C., Bochud F., Bourhis J., Moeckli R., Adrian G., 2023/11/15. International journal of radiation oncology, biology, physics, 117 (4) pp. 1007-1017. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E35A0EBD9890]
Nitrogen isotopic composition as a gauge of tumor cell anabolism-to-catabolism ratio.
Straub M., Auderset A., de Leval L., Piazzon N., Maison D., Vozenin M.C., Ollivier J., Petit B., Sigman D.M., Martínez-García A., 2023/11/13. Scientific reports, 13 (1) p. 19796. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2CF08611B7FA]
 
FLASH-RT does not affect chromosome translocations and junction structures beyond that of CONV-RT dose-rates.
Barghouth P.G., Melemenidis S., Montay-Gruel P., Ollivier J., Viswanathan V., Jorge P.G., Soto L.A., Lau B.C., Sadeghi C., Edlabadkar A. et al., 2023/11. Radiotherapy and oncology, 188 p. 109906. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_370F06589CF6]
 
Need for standardization in the use of structures in the intensity-modulated radiation therapy planning of head and neck cancers, a GORTEC study.
Özer Ö., Shafi H., O'Reilly D., Loiseau C., Dejean C., Bourhis J., Thariat J., 2023/11. Radiotherapy and oncology, 188 p. 109895. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1B42004D5655]
Response of Brain and Meningeal Metastases to Trastuzumab-Deruxtecan in a Patient with HER2-Low Breast Cancer: A Case Report.
Wolf B., Dunet V., Dubruc E., Dolcan A., Nicod Lalonde M., Schiappacasse L., Zaman K., 2023/11. Case reports in oncology, 16 (1) pp. 1425-1435. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7C9285AA6C6A]
 
Single fraction and hypofractionated radiosurgery for perioptic meningiomas—tumor control and visual outcomes: a systematic review and meta-analysis
Peters David R., Asher Anthony, Conti Alfredo, Schiappacasse Luis, Daniel Roy T., Levivier Marc, Tuleasca Constantin, 2023/10/28. Neurosurgical Review, 46 (1).
[DOI][WoS][Pmid][serval:BIB_78DFF6A25E85]
Recurrences of ventricular tachycardia after stereotactic arrhythmia radioablation arise outside the treated volume: analysis of the Swiss cohort.
Herrera Siklody C., Schiappacasse L., Jumeau R., Reichlin T., Saguner A.M., Andratschke N., Elicin O., Schreiner F., Kovacs B., Mayinger M. et al., 2023/10/05. Europace, 25 (10). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F98C44DB404D]
 
Gestational choriocarcinoma.
Bogani G., Ray-Coquard I., Mutch D., Vergote I., Ramirez P.T., Prat J., Concin N., Ngoi NYL, Coleman R.L., Enomoto T. et al., 2023/10/02. International journal of gynecological cancer, 33 (10) pp. 1504-1514. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0AFE8D23CBFC]
Clinical implementation of deep learning-based automated left breast simultaneous integrated boost radiotherapy treatment planning.
Zeverino M., Piccolo C., Wuethrich D., Jeanneret-Sozzi W., Marguet M., Bourhis J., Bochud F., Moeckli R., 2023/10. Physics and imaging in radiation oncology, 28 p. 100492. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_03629A515559]
 
Dosimetry of the PIM1 Pion Beam at the Paul Scherrer Institute for Radiobiological Studies of Mice.
Desorgher L., Stabilini A., Rostomyan T., Reggiani D., Hajdas W., Marcinkowski R.M., Vozenin M.C., Limoli C.L., Yukihara E.G., Bailat C., 2023/10/01. Radiation research, 200 (4) pp. 357-365. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BAE3CAA4E2E0]
Influence of optimisation parameters on directly deliverable Pareto fronts explored for prostate cancer.
Wüthrich D., Zeverino M., Bourhis J., Bochud F., Moeckli R., 2023/10. Physica medica, 114 p. 103139. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7FC036C4B1A6]
Stereotactic arrhythmia radioablation: A multicenter pre-post intervention safety evaluation of the implantable cardioverter-defibrillator function.
van der Ree M.H., Hoeksema W.F., Luca A., Visser J., Balgobind B.V., Zumbrink M., Spier R., Herrera-Siklody C., Lee J., Bates M. et al., 2023/09/12. Radiotherapy and oncology, 189 p. 109910. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E3F5CBDEA9BF]
3D-conformal very-high energy electron therapy as candidate modality for FLASH-RT: A treatment planning study for glioblastoma and lung cancer.
Böhlen T.T., Germond J.F., Traneus E., Vallet V., Desorgher L., Ozsahin E.M., Bochud F., Bourhis J., Moeckli R., 2023/09. Medical physics, 50 (9) pp. 5745-5756. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AE91AE049264]
The sparing effect of FLASH-RT on synaptic plasticity is maintained in mice with standard fractionation.
Limoli C.L., Kramár E.A., Almeida A., Petit B., Grilj V., Baulch J.E., Ballesteros-Zebadua P., Loo B.W., Wood M.A., Vozenin M.C., 2023/09. Radiotherapy and oncology, 186 p. 109767. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4275AE8CF8AF]
 
EPAC1 inhibition protects the heart from doxorubicin-induced toxicity.
Mazevet M., Belhadef A., Ribeiro M., Dayde D., Llach A., Laudette M., Belleville T., Mateo P., Gressette M., Lefebvre F. et al., 2023/08/08. eLife, 12 pp. e83831. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_55FAD703BC5E]
 
Influence of the Hypersensitivity to Low Dose Phenomenon on the Tumor Response to Hypofractionated Stereotactic Body Radiation Therapy.
Le Reun E., Granzotto A., Pêtre A., Bodgi L., Beldjoudi G., Lacornerie T., Vallet V., Bouchet A., Al-Choboq J., Bourguignon M. et al., 2023/08/05. Cancers, 15 (15) p. 3979. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BEF17EF87EE2]
 
Brain morphometry in older adults with and without dementia using extremely rapid structural scans.
Elliott M.L., Hanford L.C., Hamadeh A., Hilbert T., Kober T., Dickerson B.C., Mair R.W., Eldaief M.C., Buckner R.L., 2023/08/01. NeuroImage, 276 p. 120173. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1BDAC3C61F06]
 
Effects of stereotactic arrhythmia radioablation on left ventricular ejection fraction and valve function over time.
van der Ree M.H., Luca A., Herrera Siklody C., Le Bloa M., Pascale P., Porretta A.P., Teres C.C., Solana Munoz J., Hoeksema W.F., Domenichini G. et al., 2023/08. Heart rhythm, 20 (8) pp. 1206-1207. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_440E0B6F4F30]
Long-term results from a clinical study of xevinapant plus chemoradiotherapy in people with high-risk locally advanced squamous cell carcinoma of the head and neck: a plain language summary.
Tao Y., Sun X.S., Pointreau Y., Tourneau C.L., Sire C., Gollmer K., Crompton P., Bourhis J., 2023/08. Future oncology, 19 (26) pp. 1769-1776. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_41AB188BFB77]
Proton beam radiation therapy for vestibular schwannomas-tumor control and hearing preservation rates: a systematic review and meta-analysis.
Santacroce A., Trandafirescu M.F., Levivier M., Peters D., Fürweger C., Toma-Dasu I., George M., Daniel R.T., Maire R., Nakamura M. et al., 2023/07/04. Neurosurgical review, 46 (1) p. 163. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_27EA9FA9F59D]
Reply to comments on "Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation".
Herrera Siklody C., Pruvot E., Schiappacasse L., 2023/07. Clinical and translational radiation oncology, 41 p. 100588. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FBA0D083017A]
 
Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT.
Benkhaled S., Diakité K., Jullian N., Poeta S., Vandekerkhove C., Van Houtte P., Van Gestel D., De Caluwé A., 2023/06/28. Radiation oncology, 18 (1) p. 105. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_20A13ADDAFBD]
 
Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulation.
Meziani L., Gerbé de Thoré M., Clémenson C., Liu W., Laurent P.A., Mondini M., Vozenin M.C., Deutsch E., 2023/06. Journal for immunotherapy of cancer, 11 (6) pp. e006846. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4E1994F97409]
 
Orbital follicular lymphoma with large cell component treated with low-dose radiotherapy: A case report and review of literature.
Bennassi A., Girinsky T., 2023/06. Cancer radiotherapie, 27 (4) pp. 337-340. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B992EE852614]
 
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis.
Petit C., Lee A., Ma J., Lacas B., Ng W.T., Chan ATC, Hong R.L., Chen M.Y., Chen L., Li W.F. et al., 2023/06. The Lancet. Oncology, 24 (6) pp. 611-623. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F33F59DE3516]
The Relevance of Biologically Effective Dose for Hearing Preservation After Stereotactic Radiosurgery for Vestibular Schwannomas: A Retrospective Longitudinal Study.
Tuleasca C., Toma-Dasu I., Duroux S., Starnoni D., George M., Maire R., Daniel R.T., Patin D., Schiappacasse L., Dasu A. et al., 2023/06/01. Neurosurgery, 92 (6) pp. 1216-1226. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9F3810ACEC4F]
 
Recurrences of ventricular tachycardia after stereotactic arrhythmia radioablation arise outside the treated volume: analysis of the Swiss cohort
Herrera Siklody C, Schiappacasse L, Jumeau R, Reichlin T, Saguner A, Andratschke N, Elicin O, Kovacs B, Mayinger M, Huber A et al., 2023/05/24. pp. euad122.305 dans Europace, EHRA Congress 2023.
[DOI][serval:BIB_80E28F13590A]
 
Elucidating the neurological mechanism of the FLASH effect in juvenile mice exposed to hypofractionated radiotherapy.
Allen B.D., Alaghband Y., Kramár E.A., Ru N., Petit B., Grilj V., Petronek M.S., Pulliam C.F., Kim R.Y., Doan N.L. et al., 2023/05/04. Neuro-oncology, 25 (5) pp. 927-939. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_59C4BBA5ABCD]
 
Leiomyosarcoma of the lower rectum managed by radiotherapy and surgery: A case report and review of literature.
Bennassi A., Souhail H., Lo Cicero A., Durigova A., Salati E., 2023/05. Cancer radiotherapie, 27 (3) pp. 235-239. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C145FDC40637]
 
Novel unconventional radiotherapy techniques: Current status and future perspectives - Report from the 2nd international radiation oncology online seminar.
Tubin S., Vozenin M.C., Prezado Y., Durante M., Prise K.M., Lara P.C., Greco C., Massaccesi M., Guha C., Wu X. et al., 2023/05. Clinical and translational radiation oncology, 40 p. 100605. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CCA76D28FED0]
 
OC-0269 Early toxicity of SBRT for oligometastatic cancer patients in the EORTC/ESTRO OligoCare cohort
Alongi F., Ricardi U., Scorsetti M., Liv L., Balermpas P., Lievens Y., Braam P., Jereczek-Fossa B.A., Stellamans K., Ratosa I. et al., 2023/05. Radiotherapy and Oncology, 182 pp. S205.
[DOI][serval:BIB_4780C93EB224]
 
OC-0270 Metastases-directed SRT and systemic therapy: EORTC-ESTRO OligoCare delphi consensus recommendations
Kroeze S., Pavic M., Stellamans K., Lievens Y., Becherini C., Scorsetti M., Alongi F., Ricardi U., Jereczek B., Westhoff P. et al., 2023/05. Radiotherapy and Oncology, 182 pp. S205-S207.
[DOI][serval:BIB_B9ABBC3CC058]
STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe.
Grehn M., Mandija S., Miszczyk M., Krug D., Tomasik B., Stickney K.E., Alcantara P., Alongi F., Anselmino M., Aranda R.S. et al., 2023/04/15. Europace, 25 (4) pp. 1284-1295. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_32E60A3C4B28]
Reinventing Radiobiology in the Light of FLASH Radiotherapy
Limoli Charles L., Vozenin Marie-Catherine, 2023/04/11. Annual Review of Cancer Biology, 7 (1) pp. 1-21.
[URN][DOI][WoS][serval:BIB_10ABEA63A3A9]
Independent Reproduction of the FLASH Effect on the Gastrointestinal Tract: A Multi-Institutional Comparative Study.
Valdés Zayas A., Kumari N., Liu K., Neill D., Delahoussaye A., Gonçalves Jorge P., Geyer R., Lin S.H., Bailat C., Bochud F. et al., 2023/04/02. Cancers, 15 (7) p. 2121. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_65710DEED677]
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
Tao Y., Sun X.S., Pointreau Y., Le Tourneau C., Sire C., Kaminsky M.C., Coutte A., Alfonsi M., Calderon B., Boisselier P. et al., 2023/04. European journal of cancer, 183 pp. 24-37. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4F4CBA34EB3A]
Ré-irradiation de compression médullaire sur foyer d’hématopoïèse extra médullaire : présentation d’un cas [Re-irradiation of bone marrow compression on a focus of extra medullary hematopoiesis: Presentation of a case]
Bernard G., Bennassi A., Dereme J., Ozsahin M., Kinj R., 2023/04. Cancer radiotherapie, 27 (2) pp. 158-162. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5743992797E8]
Toxicity, quality of life, and PSA control after 50 Gy stereotactic body radiation therapy to the dominant intraprostatic nodule with the use of a rectal spacer: results of a phase I/II study.
Cloitre M., Valerio M., Mampuya A., Rakauskas A., Berthold D., Tawadros T., Meuwly J.Y., Heym L., Duclos F., Vallet V. et al., 2023/04/01. The British journal of radiology, 96 (1145) p. 20220803. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CB3AC2C2AFDE]
 
Uncovering the Protective Neurologic Mechanisms of Hypofractionated FLASH Radiotherapy.
Alaghband Y., Allen B.D., Kramár E.A., Zhang R., Drayson OGG, Ru N., Petit B., Almeida A., Doan N.L., Wood M.A. et al., 2023/04. Cancer research communications, 3 (4) pp. 725-737. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_84BA1980C086]
 
In Reply to Horst et al.
Böhlen T.T., Germond J.F., Bochud F., Bailat C., Moeckli R., Bourhis J., Vozenin M.C., Ozsahin E.M., 2023/03/15. International journal of radiation oncology, biology, physics, 115 (4) pp. 1007-1009. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1EAB447A4311]
 
How Stereotactic Radiotherapy Changed the Landscape in Cancer Care.
Kinj R., Bourhis J., 2023/03/13. Cancers, 15 (6) p. 1734. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_31D0A4E5E665]
Outcomes and endpoints of relevance in gynecologic cancer clinical trials.
Madariaga A., Sanchez-Bayona R., Herrera F.G., Ramirez P.T., González Martín A., 2023/03/06. International journal of gynecological cancer, 33 (3) pp. 323-332. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C322E7412FC8]
Salvage LATTICE radiotherapy for a growing tumour despite conventional radio chemotherapy treatment of lung cancer.
Kinj R., Casutt A., Nguyen-Ngoc T., Mampuya A., Schiappacasse L., Bourhis J., Huck C., Patin D., Marguet M., Zeverino M. et al., 2023/03. Clinical and translational radiation oncology, 39 p. 100557. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_FD65C693CBE6]
Inhibiting the inhibitors: Development of the IAP inhibitor xevinapant for the treatment of locally advanced squamous cell carcinoma of the head and neck.
Ferris R.L., Harrington K., Schoenfeld J.D., Tahara M., Esdar C., Salmio S., Schroeder A., Bourhis J., 2023/02. Cancer treatment reviews, 113 p. 102492. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4BDB9A2425F8]
 
Lung stereotactic radiation therapy: Intercomparison of irradiation devices in terms of outcome and predictive factors.
Le Reun E., Casutt A., Durham A., Bouchaab H., Romano E., Lovis A., Krueger T., Von Garnier C., Özsahin E.M., Kinj R., 2023/02. Cancer radiotherapie, 27 (1) pp. 31-41. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0833BFD8386F]
Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy?
Benkhaled S., Peters C., Jullian N., Arsenijevic T., Navez J., Van Gestel D., Moretti L., Van Laethem J.L., Bouchart C., 2023/01/26. Cancers, 15 (3) p. 768. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4FBF2C2F0022]
 
A rigorous behavioral testing platform for the assessment of radiation-induced neurological outcomes
Drayson Olivia G.G., Vozenin Marie-Catherine, Limoli Charles L., 2023. pp. 177-197 dans Radiation Oncology and Radiotherapy, part C, Elsevier.
[DOI][WoS][Pmid][serval:BIB_CD4CAE330E1F]
Case report: First-in-human combined low-dose whole-heart irradiation and high-dose stereotactic arrhythmia radioablation for immunosuppressive refractory cardiac sarcoidosis and ventricular tachycardia.
van der Ree M.H., Herrera Siklody C., Le Bloa M., Pascale P., Porretta A.P., Teres C.C., Solana Munoz J., Luca A., Domenichini G., Ozasahin M. et al., 2023. Frontiers in cardiovascular medicine, 10 p. 1213165. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FA14CF085E93]
 
Opportunities and challenges of low-dose radiation to enable immunotherapy efficacy
Passelli Katiuska, Repáraz David, Herrera Fernanda G., 2023. pp. 137-156 dans Ionizing Radiation and the Immune Response, part B, Elsevier.
[URN][DOI][WoS][Pmid][serval:BIB_65F7113616CD]
 
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial.
Tao Y., Biau J., Sun X.S., Sire C., Martin L., Alfonsi M., Prevost J.B., Modesto A., Lafond C., Tourani J.M. et al., 2023/01. Annals of oncology, 34 (1) pp. 101-110. Peer-reviewed.
[DOI][Pmid][serval:BIB_5988D0B3696F]
Postoperative SBRT in the treatment of early-stage oropharyngeal and oral cavity cancers with high-risk margins: A dosimetric comparison of volumetric modulated arc therapy with or without non-coplanar arcs and acute toxicity outcomes from the STEREOPOSTOP GORTEC 2017-03 phase 2 trial.
Biau J., Lopez L., Thivat E., Casile M., Millardet C., Saroul N., Pham-Dang N., Molnar I., Bourhis J., Lapeyre M., 2023/01. Clinical and translational radiation oncology, 38 pp. 169-174. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DB540CCA7ED5]
 
Radio-induced lymphopenia in the era of anti-cancer immunotherapy
de Kermenguy François, Meziani Lydia, Mondini Michele, Clémenson Céline, Morel Daphné, Deutsch Eric, Robert Charlotte, 2023. pp. 1-30 dans International Review of Cell and Molecular Biology, Elsevier.
[DOI][WoS][Pmid][serval:BIB_AE48AC906BC7]
 
Response to: Limbic system damage following SARS-CoV2 infection.
Voruz P., Cionca A., Assal F., Péron J.A., 2023. Brain communications, 5 (6) pp. fcad342. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A9CAF7254936]
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.
Gregucci F., Spada S., Barcellos-Hoff M.H., Bhardwaj N., Chan Wah Hak C., Fiorentino A., Guha C., Guzman M.L., Harrington K., Herrera F.G. et al., 2023. Oncoimmunology, 12 (1) p. 2222560. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E70CC601A800]
2022
 
AIRO GORTEC consensus on postoperative radiotherapy (PORT) in low-intermediate risk early stages oral squamous cell cancers (OSCC).
Merlotti A., Alterio D., Orlandi E., Racadot S., Bonomo P., Franco P., D'Angelo E., Ursino S., Pointreau Y., Lapeyre M. et al., 2022/12. Radiotherapy and oncology, 177 pp. 95-104. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A8EE44EDCADD]
 
FLASHlab@PITZ: New R&D platform with unique capabilities for electron FLASH and VHEE radiation therapy and radiation biology under preparation at PITZ.
Stephan F., Gross M., Grebinyk A., Aboulbanine Z., Amirkhanyan Z., Budach V., Ehrhardt V.H., Faus-Golfe A., Frohme M., Germond J.F. et al., 2022/12. Physica medica, 104 pp. 174-187. Peer-reviewed.
[DOI][Pmid][serval:BIB_B4F1E1A64EA0]
 
Normal Tissue Sparing by FLASH as a Function of Single-Fraction Dose: A Quantitative Analysis.
Böhlen T.T., Germond J.F., Bourhis J., Vozenin M.C., Ozsahin E.M., Bochud F., Bailat C., Moeckli R., 2022/12/01. International journal of radiation oncology, biology, physics, 114 (5) pp. 1032-1044. Peer-reviewed.
[DOI][Pmid][serval:BIB_03FA7A108554]
The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
Böhlen T.T., Germond J.F., Bourhis J., Bailat C., Bochud F., Moeckli R., 2022/12. Medical physics, 49 (12) pp. 7672-7682. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A5B6F25E2105]
 
Towards clinical translation of FLASH radiotherapy.
Vozenin M.C., Bourhis J., Durante M., 2022/12. Nature reviews. Clinical oncology, 19 (12) pp. 791-803. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7711B81AAACB]
The role of single fraction Gamma Knife radiosurgery for intraventricular central neurocytomas and the utility of F-18 fluroethyltyrosine: two case reports.
Dedeciusova M., Prior J.O., Schiappacasse L., Patin D., Levivier M., Tuleasca C., 2022/11/28. Journal of medical case reports, 16 (1) p. 441. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F60A7D1361A1]
Pneumopathies radiques - Pathophysiologie, classification, facteurs de risque et prise en charge en 2022 [Radiation-induced pneumonitis : pathophysiology, risk factors and work-up in 2022]
Bongard C., Campaner R.M., Bernard G., Lovis A., Von Garnier C., Kinj R., Casutt A., 2022/11/16. Revue medicale suisse, 18 (804) pp. 2134-2142. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_34595C5F5CD7]
 
Orbital amyloidosis and radiotherapy: A case report and review of literature.
Bennassi A., Kinj R., Chaabouni S., Khanfir K., 2022/11. Cancer radiotherapie, 26 (8) pp. 1070-1074. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4090FD39342B]
Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation.
Herrera Siklody C., Pruvot E., Pascale P., Kinj R., Jumeau R., Le Bloa M., Teres C., Domenichini G., Porretta A.P., Ozsahin M. et al., 2022/11. Clinical and translational radiation oncology, 37 pp. 89-93. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0DB36A9EB031]
VoiceS: voice quality after transoral CO<sub>2</sub> laser surgery versus single vocal cord irradiation for unilateral stage 0 and I glottic larynx cancer-a randomized phase III trial.
Reinhardt P., Giger R., Seifert E., Shelan M., Riggenbach E., Terribilini D., Joosten A., Schanne D.H., Aebersold D.M., Manser P. et al., 2022/10/27. Trials, 23 (1) p. 906. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AA7128E6DDF6]
 
Recurrences after stereotactic arrhythmia radioablation for refractory ventricular tachycardia
Herrera Siklody C, Schiappacasse L, Jumeau R, Le Bloa M, Ozsahin M, Teres Castillo C, Moeckli R, Porretta A P, Pascale P, Domenichini G et al., 2022/10/03. European Heart Journal, 43 (Supplement_2).
[DOI][serval:BIB_31F8D91F10B7]
 
Comparing radiolytic production of H<sub>2</sub>O<sub>2</sub> and development of Zebrafish embryos after ultra high dose rate exposure with electron and transmission proton beams.
Kacem H., Psoroulas S., Boivin G., Folkerts M., Grilj V., Lomax T., Martinotti A., Meer D., Ollivier J., Petit B. et al., 2022/10. Radiotherapy and oncology, 175 pp. 197-202. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9CD75B81043D]
Design and validation of a dosimetric comparison scheme tailored for ultra-high dose-rate electron beams to support multicenter FLASH preclinical studies.
Jorge P.G., Melemenidis S., Grilj V., Buchillier T., Manjappa R., Viswanathan V., Gondré M., Vozenin M.C., Germond J.F., Bochud F. et al., 2022/10. Radiotherapy and oncology, 175 pp. 203-209. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FC59EAAA1608]
 
FLASH Radiotherapy & Particle Therapy conference, FRPT2021.
Vozenin M.C., Schüller A., Dutreix M., Kirkby K., Baumann M., Coppes R.P., Thwaites D., 2022/10. Radiotherapy and oncology, 175 pp. 167-168. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_835E1B1C60D6]
Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma.
Gaide O., Herrera F.G., Jeanneret Sozzi W., Gonçalves Jorge P., Kinj R., Bailat C., Duclos F., Bochud F., Germond J.F., Gondré M. et al., 2022/09. Radiotherapy and oncology, 174 pp. 87-91. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3BC621CB1990]
Dose- and Volume-Limiting Late Toxicity of FLASH Radiotherapy in Cats with Squamous Cell Carcinoma of the Nasal Planum and in Mini Pigs.
Rohrer Bley C., Wolf F., Gonçalves Jorge P., Grilj V., Petridis I., Petit B., Böhlen T.T., Moeckli R., Limoli C., Bourhis J. et al., 2022/09/01. Clinical cancer research, 28 (17) pp. 3814-3823. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_83A4D24300BD]
Commissioning and validation of RayStation treatment planning system for CyberKnife M6.
Gondré M., Conrad M., Vallet V., Bourhis J., Bochud F., Moeckli R., 2022/08. Journal of applied clinical medical physics, 23 (8) pp. e13732. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_86D6807F70CB]
A new mouse model of radiation-induced liver disease reveals mitochondrial dysfunction as an underlying fibrotic stimulus.
Melin N., Yarahmadov T., Sanchez-Taltavull D., Birrer F.E., Brodie T.M., Petit B., Felser A., Nuoffer J.M., Montani M., Vozenin M.C. et al., 2022/07. JHEP reports, 4 (7) p. 100508. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0CD190CF6BA1]
Low-dose irradiation for reversing immunotherapy resistance: how to translate?
Ochoa-de-Olza M., Bourhis J., Coukos G., Herrera F.G., 2022/07. Journal for immunotherapy of cancer, 10 (7) pp. e004939. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DBBB9D3370A5]
 
Fractionated Stereotactic Radiation Therapy for Pituitary Adenomas: An alternative escalating protocol of hypofractionated stereotactic radiotherapy delivering 35Gy in 5 fractions.
Sumodhee S., Atallah V., Kinj R., Doyen J., L'Homel B., Gillon P., Paquis P., Almairac F., Hieronimus S., Schiappa R. et al., 2022/06. Cancer radiotherapie, 26 (4) pp. 557-562. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8252BA6D37ED]
 
International assessment of interobserver reproducibility of flap delineation in head and neck carcinoma.
Beddok A., Guzene L., Coutte A., Thomson D., Yom S.S., Calugaru V., Blais E., Gilliot O., Racadot S., Pointreau Y. et al., 2022/06. Acta oncologica, 61 (6) pp. 672-679. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ECADD78C324F]
Place de la radiothérapie stéréotaxique dans le cancer du poumon non à petites cellules en oligoprogression [Place of stereotactic radiotherapy in oligoprogressive non-small cell lung cancer]
Bernard G., Klausner G., Blais E., Canova C.H., Bourhis J., Troussier I., 2022/06/01. Revue medicale suisse, 18 (784) pp. 1125-1133. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A69739694680]
Prise en charge des métastases cérébrales en 2022 [Management of brain metastases in 2022]
Schiappacasse L., Kinj R., De Micheli R., Mederos N., Tuleasca C., Cossu G., Dunet V., Levivier M., Bourhis J., Hottinger A.F., 2022/05/18. Revue medicale suisse, 18 (782) pp. 976-983. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C341F49A8ECA]
 
Radiographic-anatomy, natural history and extension pathways of parotid and submandibular gland cancers.
Biau J., Nutting C., Langendijk J.A., Frédéric-Moreau T., Thariat J., Piram L., Bellini R., Saroul N., Pham Dang N., O'Sullivan B. et al., 2022/05. Radiotherapy and oncology, 170 pp. 48-54. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0FE2485183E1]
 
Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design.
Bourhis J., Burtness B., Licitra L.F., Nutting C., Schoenfeld J.D., Omar M., Bouisset F., Nauwelaerts H., Urfer Y., Zanna C. et al., 2022/05. Future oncology, 18 (14) pp. 1669-1678. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0A17DBE552A8]
Improving Patients' Life Quality after Radiotherapy Treatment by Predicting Late Toxicities.
Lapierre A., Bourillon L., Larroque M., Gouveia T., Bourgier C., Ozsahin M., Pèlegrin A., Azria D., Brengues M., 2022/04/22. Cancers, 14 (9) p. 2097. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0FEF06F590D0]
Bazilläre Schichtablösung (BALAD) in einer makulären Aderhautmetastase eines niedriggradigen rektalen Adenokarzinoms [Bacillary Layer Detachment (BALAD) in Macular Choroidal Metastasis of a Low-grade Rectal Adenocarcinoma]
Sophie Prodʼhom, Gaillard M.C., Vaclavik V., DeGottrau P., Odermatt R., Schiappacasse L., Schalenbourg A., 2022/04. Klinische Monatsblatter fur Augenheilkunde, 239 (4) pp. 582-585. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_92AF99AC5035]
 
Endobronchial Clip Device Insertion for Tracking Central Lesions.
Casutt A., Kinj R., Ozsahin E.M., von Garnier C., Gonzalez M., Lovis A., 2022/04/01. Journal of bronchology & interventional pulmonology, 29 (2) pp. e18-e20. Peer-reviewed.
[DOI][Pmid][serval:BIB_88984DEF5126]
Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLC.
Ochoa-de-Olza M., Bourhis J., Coukos G., Herrera F.G., 2022/04. The Lancet. Oncology, 23 (4) pp. e157. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BC56553604E1]
Verzögerte Diagnose eines Lungenkarzinoms, das sich als choroidale Metastase in einem COVID-19-Patienten präsentierte und am Anfang mit Osimertinib behandelt wurde [Delayed Diagnosis of Lung Carcinoma Presenting as Choroidal Metastasis in a COVID-19 Patient and Initially Treated with Osimertinib]
Haeller C.N., Khamsy L., Kloepper J., Schiappacasse L., Bouchaab H., Peters S., Schalenbourg A., 2022/04. Klinische Monatsblatter fur Augenheilkunde, 239 (4) pp. 586-589. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B66EE0FBC45A]
Fiducial markers for stereotactic lung radiation therapy: review of the transthoracic, endovascular and endobronchial approaches.
Casutt A., Kinj R., Ozsahin E.M., von Garnier C., Lovis A., 2022/03/31. European respiratory review, 31 (163) p. 210149. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_784DA94BCCE2]
 
Lighting up the tumor fire with low-dose irradiation.
Herrera F.G., Romero P., Coukos G., 2022/03. Trends in immunology, 43 (3) pp. 173-179. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_49751A0F49EB]
Technical note: Validation of an ultrahigh dose rate pulsed electron beam monitoring system using a current transformer for FLASH preclinical studies.
Gonçalves Jorge P., Grilj V., Bourhis J., Vozenin M.C., Germond J.F., Bochud F., Bailat C., Moeckli R., 2022/03. Medical physics, 49 (3) pp. 1831-1838. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D66CA0261E74]
 
Ultra-high dose rate electron beams and the FLASH effect: From preclinical evidence to a new radiotherapy paradigm.
Schüler E., Acharya M., Montay-Gruel P., Loo B.W., Vozenin M.C., Maxim P.G., 2022/03. Medical physics, 49 (3) pp. 2082-2095. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_01434BB9E9EB]
Nurse-Led Consultation and Symptom Burden in Patients with Head and Neck Cancer: A Comparative Analysis of Routine Clinical Data.
Luta X., Colomer-Lahiguera S., Martins Cardoso R.J., Hof F., Savoie M., Schuler C., Wicht J., Fucina N., Debarge P., Ninane F. et al., 2022/02/26. Cancers, 14 (5) p. 1227. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CAA0E94D9DB3]
 
Stereotactic Body Radiation Therapy in Patients with Oligometastatic Disease: Clinical State of the Art and Perspectives.
Kinj R., Muggeo E., Schiappacasse L., Bourhis J., Herrera F.G., 2022/02/23. Cancers, 14 (5) p. 1152. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1222E7500D6E]
 
Can UHDR devices with only a few fixed beams provide competitive treatments plans compared to VMAT?
Böhlen T. T., Germond J.-F., Traneus E., Desorgher L., Vozenin M.-C., Bourhis J., Bailat C., Bochud F., Moeckli R., 2022/02. Physica Medica, 94 pp. S37–S38.
[DOI][serval:BIB_2C7196825B4E]
 
Laparoscopic adrenalectomy for metastatic disease
Matter Maurice, Zingg Tobias, Schiappacasse Luis, 2022/02. pp. e144 dans European Journal of Surgical Oncology.
[DOI][serval:BIB_B7E76EB25081]
Validation of Monte Carlo dose calculation algorithm for CyberKnife multileaf collimator.
Gondré M., Marsolat F., Bourhis J., Bochud F., Moeckli R., 2022/02. Journal of applied clinical medical physics, 23 (2) pp. e13481. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5E1F27A9CF4B]
Association of the Posterior Acromion Extension with Glenoid Retroversion: A CT Study in Normal and Osteoarthritic Shoulders.
Terrier A., Becce F., Vauclair F., Farron A., Goetti P., 2022/01/12. Journal of clinical medicine, 11 (2) p. 351.. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BE6DC28A0C40]
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.
Herrera F.G., Ronet C., Ochoa de Olza M., Barras D., Crespo I., Andreatta M., Corria-Osorio J., Spill A., Benedetti F., Genolet R. et al., 2022/01. Cancer discovery, 12 (1) pp. 108-133. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D82928F3BB2B]
 
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients.
Blanchard P., Lee AWM, Carmel A., Wai Tong N., Ma J., Chan ATC, Hong R.L., Chen M.Y., Chen L., Li W.F. et al., 2022/01. Clinical and translational radiation oncology, 32 pp. 59-68. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_22AE66170C77]
 
Overcoming Immune Resistance With Radiation Therapy in Prostate Cancer.
Mulvey A., Muggeo-Bertin E., Berthold D.R., Herrera F.G., 2022. Frontiers in immunology, 13 p. 859785. Peer-reviewed.
[DOI][Pmid][serval:BIB_DE34735C811E]
Re-irradiation of recurrent vertebral metastasis after two previous spinal cord irradiation: A case report.
Bentahila R., Kinj R., Huck C., El Houat Y., Mampuya A., Tuleasca C., Ozsahin M., Bourhis J., Schiappacasse L., 2022. Frontiers in oncology, 12 p. 995376. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5064554EC04A]
 
Understanding the FLASH effect to unravel the potential of ultra-high dose rate irradiation.
Kacem H., Almeida A., Cherbuin N., Vozenin M.C., 2022. International journal of radiation biology, 98 (3) pp. 506-516. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DC23578CAFF2]
2021
 
A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patients.
Khalladi N., Dejean C., Bosset M., Pointreau Y., Kinj R., Racadot S., Castelli J., Huguet F., Renard S., Guihard S. et al., 2021/12. Cancer radiotherapie, 25 (8) pp. 755-762. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_770454ACEC36]
Infirmière clinicienne de centre du cancer : l’expérience du Centre de la prostate du CHUV [Cancer center clinical nurse: The experience of the CHUV Prostate Cancer Center]
Codeluppi C., Ninane F., Jolliet L., Glemarec P., Orcurto A., Rakauskas A., Tawadros T., Bosshard P., Eicher M., Herrera F. et al., 2021/12/01. Revue medicale suisse, 17 (761) pp. 2082-2085. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B3EF72B4777A]
 
Prognostic impact of extranodal extension in resected head and neck squamous cell carcinomas in the era of postoperative chemoradiation: A retrospective monocentric study.
Gau M., Fonseca A., Ozsahin M., Fayette J., Poupart M., Roux P.E., Schütz F., Zrounba P., Grégoire V., 2021/12. Oral oncology, 123 p. 105605. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4446FA1BC358]
 
Recommendations regarding cardiac stereotactic body radiotherapy for treatment refractory ventricular tachycardia.
Krug D., Blanck O., Andratschke N., Guckenberger M., Jumeau R., Mehrhof F., Boda-Heggemann J., Seidensaal K., Dunst J., Pruvot E. et al., 2021/12. Heart rhythm, 18 (12) pp. 2137-2145. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_67C18F8C2B74]
 
Synchrotron Microbeam Radiation Therapy for the Treatment of Lung Carcinoma: A Preclinical Study.
Trappetti V., Fernandez-Palomo C., Smyth L., Klein M., Haberthür D., Butler D., Barnes M., Shintani N., de Veer M., Laissue J.A. et al., 2021/12/01. International journal of radiation oncology, biology, physics, 111 (5) pp. 1276-1288. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5F5D0D4A4FC1]
Negative 18F-FET PET/CT in brain metastasis recurrence: a teaching case report.
Alshehri S., Prior J., Moshebah M., Schiappacasse L., Dunet V., 2021/11/22. European journal of hybrid imaging, 5 (1) p. 21. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_50442C996C6C]
 
An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiation.
Slevin F., Aitken K., Alongi F., Arcangeli S., Chadwick E., Chang A.R., Cheung P., Crane C., Guckenberger M., Jereczek-Fossa B.A. et al., 2021/11. Radiotherapy and oncology, 164 pp. 104-114. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3825294D9B35]
 
Implementation and validation of a beam-current transformer on a medical pulsed electron beam LINAC for FLASH-RT beam monitoring.
Oesterle R., Gonçalves Jorge P., Grilj V., Bourhis J., Vozenin M.C., Germond J.F., Bochud F., Bailat C., Moeckli R., 2021/11. Journal of applied clinical medical physics, 22 (11) pp. 165-171. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_670F6488D9CD]
 
Technical Note: Break-even dose level for hypofractionated treatment schedules.
Böhlen T.T., Germond J.F., Bourhis J., Vozenin M.C., Bailat C., Bochud F., Moeckli R., 2021/11. Medical physics, 48 (11) pp. 7534-7540. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A85E84A8CBCF]
On the interplay effect for moving targets treated with the CyberKnife static tracking system.
Zeverino M., Jia Y., Charosky L., Bourhis J., Bochud F.O., Moeckli R., 2021/10. Physica medica, 90 pp. 30-39. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0E0223D7988A]
Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease.
Bolla M., Neven A., Maingon P., Carrie C., Boladeras A., Andreopoulos D., Engelen A., Sundar S., van der Steen-Banasik E.M., Armstrong J. et al., 2021/09/20. Journal of clinical oncology, 39 (27) pp. 3022-3033. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9270D0BDCDC3]
A Locally Advanced Endometrioid Adenocarcinoma Arising from Vaginal Endometriosis: Management and Review of the Literature
Costanza M., Herrera F.G., Hastir D., Mathevet P., Sarivalasis A., 2021/09/17. Reports, 4 (3) p. 29. Peer-reviewed.
[URN][DOI][WoS][serval:BIB_47314A3E8C85]
A new method to visualize and to spare the ureters during SBRT for oligo metastatic patients.
Muggeo-Bertin E., Moeckli R., Vallet V., Berthold D., Godin S., Bourhis J., Herrera F.G., 2021/09. Technical innovations & patient support in radiation oncology, 19 pp. 7-10. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5205796889DB]
Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose.
Wilke L., Moustakis C., Blanck O., Albers D., Albrecht C., Avcu Y., Boucenna R., Buchauer K., Etzelstorfer T., Henkenberens C. et al., 2021/09. Strahlentherapie und Onkologie, 197 (9) pp. 836-846. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BF01D4ABC5DF]
Sex-Specific Differences in Toxicity Following Systemic Paclitaxel Treatment and Localized Cardiac Radiotherapy.
Chmielewski-Stivers N., Petit B., Ollivier J., Monceau V., Tsoutsou P., Quintela Pousa A., Lin X., Limoli C., Vozenin M.C., 2021/08/06. Cancers, 13 (16) p. 3973. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EC36C22A988A]
 
CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors.
Labiano S., Roh V., Godfroid C., Hiou-Feige A., Romero J., Sum E., Rapp M., Boivin G., Wyss T., Simon C. et al., 2021/07/15. Clinical cancer research, 27 (14) pp. 4054-4065. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_01B309C22867]
Distinct nitrogen isotopic compositions of healthy and cancerous tissue in mice brain and head&neck micro-biopsies.
Straub M., Sigman D.M., Auderset A., Ollivier J., Petit B., Hinnenberg B., Rubach F., Oleynik S., Vozenin M.C., Martínez-García A., 2021/07/13. BMC cancer, 21 (1) p. 805. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_81B033323C18]
Active surveillance in males with low- to intermediate-risk localized prostate cancer: A modern prospective cohort study.
Rakauskas A., Tawadros T., Lucca I., Herrera F., Bourhis J., Burruni R., Gomes M.N., Codeluppi C., Jolliet L., La Rosa S. et al., 2021/07. Investigative and clinical urology, 62 (4) pp. 416-422. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_11DA8B398364]
 
Characteristics of very high-energy electron beams for the irradiation of deep-seated targets.
Böhlen T.T., Germond J.F., Traneus E., Bourhis J., Vozenin M.C., Bailat C., Bochud F., Moeckli R., 2021/07. Medical physics, 48 (7) pp. 3958-3967. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6EC1E00C718A]
 
Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensus.
Carsuzaa F., Lapeyre M., Gregoire V., Maingon P., Beddok A., Marcy P.Y., Salleron J., Coutte A., Racadot S., Pointreau Y. et al., 2021/07. Radiotherapy and oncology, 160 pp. 140-147. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F8E301B5142A]
Prise en charge des sarcomes des tissus mous abdominaux [Management of abdominal soft tissue sarcomas]
Djafarrian R., Zingg T., Digklia A., Becce F., Özsahin E.M., La Rosa S., Demartines N., Matter M., 2021/06/16. Revue medicale suisse, 17 (743) pp. 1172-1176. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B1CF53F8316E]
 
Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancer.
Bourhis J., Stein A., Paul de Boer J., Van Den Eynde M., Gold K.A., Stintzing S., Becker J.C., Moran M., Schroeder A., Pennock G. et al., 2021/06. Cancer treatment reviews, 97 p. 102172. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_90CC642BEF44]
Commissioning of an ultra-high dose rate pulsed electron beam medical LINAC for FLASH RT preclinical animal experiments and future clinical human protocols.
Moeckli R., Gonçalves Jorge P., Grilj V., Oesterle R., Cherbuin N., Bourhis J., Vozenin M.C., Germond J.F., Bochud F., Bailat C., 2021/06. Medical physics, 48 (6) pp. 3134-3142. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_04A0655121E7]
Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER).
Tougeron D., Hentzien M., Seitz-Polski B., Bani-Sadr F., Bourhis J., Ducreux M., Gaujoux S., Gorphe P., Guiu B., Hoang-Xuan K. et al., 2021/06. European journal of cancer, 150 pp. 232-239. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9B6A0DE80EF6]
Vaccination contre la COVID-19 des patients atteints de cancer solide : revue et préconisations d’un inter-groupe oncologique français (CGO, TNCD, UNICANCER) [Vaccination against COVID-19 in patients with solid cancer: Review and point of view from a French oncology inter-group (CGO, TNCD, UNICANCER)]
Tougeron D., Seitz-Polski B., Hentzien M., Bani-Sadr F., Bourhis J., Ducreux M., Gaujoux S., Gorphe P., Guiu B., Hardy-Bessard A.C. et al., 2021/06. Bulletin du cancer, 108 (6) pp. 614-626. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7ED320B63D3A]
 
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.
Petit C., Lacas B., Pignon J.P., Le Q.T., Grégoire V., Grau C., Hackshaw A., Zackrisson B., Parmar MKB, Lee J.W. et al., 2021/05. The Lancet. Oncology, 22 (5) pp. 727-736. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2F7EBB289818]
 
Endobronchial coil spring fiducial markers for CyberKnife® stereotactic body radiation therapy.
Casutt A., Noirez L., Bernasconi M., Koutsokera A., Beigelman-Aubry C., Kinj R., Ozsahin E.M., Durham A.D., von Garnier C., Lovis A., 2021/05. Respirology, 26 (5) pp. 469-476. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C98C6D8E75E9]
 
GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy.
Ancey P.B., Contat C., Boivin G., Sabatino S., Pascual J., Zangger N., Perentes J.Y., Peters S., Abel E.D., Kirsch D.G. et al., 2021/05/01. Cancer research, 81 (9) pp. 2345-2357. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A171D8D09919]
 
Impact of prophylactic cranial irradiation and hippocampal sparing on 18F-FDG brain metabolism in small cell lung cancer patients.
Chammah S.E., Allenbach G., Jumeau R., Boughdad S., Prior J.O., Nicod Lalonde M., Schaefer N., Meyer M., 2021/05. Radiotherapy and oncology, 158 pp. 200-206. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4F5C9655A438]
Stereotactic lung reirradiation for local relapse: A case series.
Kinj R., Casutt A., Bennassi A., Bouchaab H., Vallet V., Lovis A., Ozsahin M., 2021/05. Clinical and translational radiation oncology, 28 pp. 85-87. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_306A219BD9DC]
 
Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: an alternative approach for overcoming potential bias.
Caccialanza R., Cereda E., Orlandi E., Filippi A.R., Comoli P., Alberti A., Imarisio I., Pedrazzoli P., Bossi P., 2021/04/06. The American journal of clinical nutrition, 113 (4) pp. 1053-1054. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D820393C1826]
 
Reply to Caccialanza et al.
Boisselier P., Thézénas S., Flori N., Vinches M., Bourhis J., Senesse P., 2021/04/06. The American journal of clinical nutrition, 113 (4) pp. 1054-1055. Peer-reviewed.
[DOI][Pmid][serval:BIB_92C946703F47]
 
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Lee N.Y., Ferris R.L., Psyrri A., Haddad R.I., Tahara M., Bourhis J., Harrington K., Chang P.M., Lin J.C., Razaq M.A. et al., 2021/04. The Lancet. Oncology, 22 (4) pp. 450-462. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_94858614ED10]
 
Proposition de délinéation des volumes cibles anatomocliniques postopératoires de la tumeur primitive des cancers de l’ethmoïde [Proposal for the delineation of postoperative primary clinical target volumes in ethmoid cancers]
Guillemin F., Miroir J., Piram L., Bellini R., Saroul N., Pham Dang N., Boisselier P., Bourhis J., Calugaru V., Coutte A. et al., 2021/04. Cancer radiotherapie, 25 (2) pp. 200-205. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EE6DEF5C9D58]
 
Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists.
Glatzer M., Leskow P., Caparrotti F., Elicin O., Furrer M., Gambazzi F., Dutly A., Gelpke H., Guckenberger M., Heuberger J. et al., 2021/04. Translational lung cancer research, 10 (4) pp. 1960-1968. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_692D31C206F0]
Abscopal effect in a patient with malignant pleural mesothelioma treated with palliative radiotherapy and pembrolizumab.
Mampuya W.A., Bouchaab H., Schaefer N., Kinj R., La Rosa S., Letovanec I., Ozsahin M., Bourhis J., Coukos G., Peters S. et al., 2021/03. Clinical and translational radiation oncology, 27 pp. 85-88. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C82F89BA6EDB]
Detection of an asymptomatic Covid-19 patient on CBCT-imaging.
Kinj R., Bennassi A., Romano E., Scher N., Bourhis J., Ozsahin M., 2021/03. Radiotherapy and oncology, 156 pp. 199-200. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F1E31B147F23]
 
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.
Lacas B., Carmel A., Landais C., Wong S.J., Licitra L., Tobias J.S., Burtness B., Ghi M.G., Cohen EEW, Grau C. et al., 2021/03. Radiotherapy and oncology, 156 pp. 281-293. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0FC45D6CCFAA]
 
Ultra-high-dose-rate FLASH and Conventional-Dose-Rate Irradiation Differentially Affect Human Acute Lymphoblastic Leukemia and Normal Hematopoiesis.
Chabi S., To THV, Leavitt R., Poglio S., Jorge P.G., Jaccard M., Petersson K., Petit B., Roméo P.H., Pflumio F. et al., 2021/03/01. International journal of radiation oncology, biology, physics, 109 (3) pp. 819-829. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0D2E39BA99D3]
VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature.
Liapi A., Mathevet P., Herrera F.G., Hastir D., Sarivalasis A., 2021/03. Frontiers in oncology, 11 p. 641376. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0F71532CFC6B]
Anti-Ly6G binding and trafficking mediate positive neutrophil selection to unleash the anti-tumor efficacy of radiation therapy.
Boivin G., Ancey P.B., Vuillefroy de Silly R., Kalambaden P., Contat C., Petit B., Ollivier J., Bourhis J., Meylan E., Vozenin M.C., 2021/02/08. Oncoimmunology, 10 (1) p. 1876597. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_62EF59F96B75]
Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions.
Banfill K., Giuliani M., Aznar M., Franks K., McWilliam A., Schmitt M., Sun F., Vozenin M.C., Faivre Finn C., IASLC Advanced Radiation Technology committee, 2021/02. Journal of thoracic oncology, 16 (2) pp. 216-227. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F0268AA3CC5A]
 
Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice.
Montay-Gruel P., Acharya M.M., Gonçalves Jorge P., Petit B., Petridis I.G., Fuchs P., Leavitt R., Petersson K., Gondré M., Ollivier J. et al., 2021/02/01. Clinical cancer research, 27 (3) pp. 775-784. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_228C29969820]
Letter in Response to Doyen et al., "Early Toxicities After High Dose Rate Proton Therapy in Cancer Treatments".
Montay-Gruel P., Vozenin M.C., Limoli C.L., 2021. Frontiers in oncology, 11 p. 687593. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8E182B773EC4]
So-Called Serous Carcinoma of the Uterine Cervix with BRCA2 Mutation: Case Report and Review of the Literature.
Herrera Gómez R.G., Hastir D., Liapi A., Dolcan A., Herrera F.G., Mathevet P., Sarivalasis A., 2021. Case reports in oncology, 14 (3) pp. 1792-1798. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E2E089A99CB8]
 
Stereotactic Pelvic Reirradiation for Locoregional Cancer Relapse.
Kinj R., Doyen J., Hannoun-Lévi J.M., Naghavi A.O., Chand M.E., Baudin G., Ferrero J.M., François E., Evesque L., Borchiellini D. et al., 2021/01. Clinical oncology, 33 (1) pp. e15-e21. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_79D9D55EB1CB]
Unsupervised Analysis of Flow Cytometry Data in a Clinical Setting Captures Cell Diversity and Allows Population Discovery.
Baumgaertner P., Sankar M., Herrera F.G, Benedetti F., Barras D., Thierry A.C., Dangaj D., Kandalaft L.E., Coukos G., Xenarios I. et al., 2021. Frontiers in immunology, 12 p. 633910. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E707FFE34C52]
2020
 
Phase I Trial of Debio 1143, an Antagonist of Inhibitor of Apoptosis Proteins, Combined with Cisplatin Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Le Tourneau C., Tao Y., Gomez-Roca C., Cristina V., Borcoman E., Deutsch E., Bahleda R., Calugaru V., Modesto A., Rouits E. et al., 2020/12/15. Clinical cancer research, 26 (24) pp. 6429-6436. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2A8394CFA639]
 
Predictive classifier for intensive treatment of head and neck cancer.
Zakeri K., Rotolo F., Lacas B., Vitzthum L.K., Le Q.T., Gregoire V., Overgaard J., Hackshaw A., Zackrisson B., Parmar MKB et al., 2020/12/15. Cancer, 126 (24) pp. 5263-5273. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_760375410F88]
 
All Irradiations that are Ultra-High Dose Rate may not be FLASH: The Critical Importance of Beam Parameter Characterization and In Vivo Validation of the FLASH Effect.
Vozenin M.C., Montay-Gruel P., Limoli C., Germond J.F., 2020/12/01. Radiation research, 194 (6) pp. 571-572. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_03E38AFCC9D4]
 
Avelumab-cetuximab-radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH).
Tao Y., Aupérin A., Sun X., Sire C., Martin L., Coutte A., Lafond C., Miroir J., Liem X., Rolland F. et al., 2020/12. European journal of cancer, 141 pp. 21-29. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0A6D3B3BAF8B]
 
Maintenance of Tight Junction Integrity in the Absence of Vascular Dilation in the Brain of Mice Exposed to Ultra-High-Dose-Rate FLASH Irradiation.
Allen B.D., Acharya M.M., Montay-Gruel P., Jorge P.G., Bailat C., Petit B., Vozenin M.C., Limoli C., 2020/12/01. Radiation research, 194 (6) pp. 625-635. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_034F4F53B281]
 
Metachronous lung cancer resection on extracorporeal membrane oxygenation in a pneumonectomized and mediastinum irradiated patient
Koliakos Evangelos, Chiriatti Enrica, Durham André, Gonzalez Michel, Krueger Thorsten, Grange Jean-Claude, Delay Dominique, Gex Gregoire, Christodoulou Michel, Perentes Jean Yannis, 2020/12. Video-Assisted Thoracic Surgery, 5 pp. 39-39.
[DOI][WoS][serval:BIB_A76FFAC8C3F4]
 
Optimization of Alanine Measurements for Fast and Accurate Dosimetry in FLASH Radiation Therapy.
Gondré M., Jorge P.G., Vozenin M.C., Bourhis J., Bochud F., Bailat C., Moeckli R., 2020/12/01. Radiation research, 194 (6) pp. 573-579. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_47E03865D8D3]
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Lièvre A., Turpin A., Ray-Coquard I., Le Malicot K., Thariat J., Ahle G., Neuzillet C., Paoletti X., Bouché O., Aldabbagh K. et al., 2020/12. European journal of cancer, 141 pp. 62-81. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A9F032E17471]
 
Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases.
Benhmida S., Sun R., Gherga E., Hammoud Y., Rouvier J., Mauvais O., Bockel S., Louvrier A., Lebbad A., Bontemps P. et al., 2020/12. Cancer radiotherapie, 24 (8) pp. 812-819. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7FF056BC1846]
 
The European Joint Research Project UHDpulse - Metrology for advanced radiotherapy using particle beams with ultra-high pulse dose rates.
Schüller A., Heinrich S., Fouillade C., Subiel A., De Marzi L., Romano F., Peier P., Trachsel M., Fleta C., Kranzer R. et al., 2020/12. Physica medica, 80 pp. 134-150. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_056D33C03DE4]
 
The European Joint Research Project UHDpulse – Metrology for advanced radiotherapy using particle beams with ultra-high pulse dose rates
Schüller Andreas, Heinrich Sophie, Fouillade Charles, Subiel Anna, De Marzi Ludovic, Romano Francesco, Peier Peter, Trachsel Maria, Fleta Celeste, Kranzer Rafael et al., 2020/12. Physica Medica, 80 pp. 134-150.
[DOI][WoS][Pmid][serval:BIB_028F3E7E3207]
 
Ultra-High-Dose-Rate FLASH Irradiation Limits Reactive Gliosis in the Brain.
Montay-Gruel P., Markarian M., Allen B.D., Baddour J.D., Giedzinski E., Jorge P.G., Petit B., Bailat C., Vozenin M.C., Limoli C. et al., 2020/12/01. Radiation research, 194 (6) pp. 636-645. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_82F091805B85]
 
Vertebral compression fracture during stereotactic body radiotherapy for spinal metastasis: A rare case of tracking failure.
Godin S., Durham A.D., Schiappacasse L., Ozsahin E.M., Vilotte F., 2020/12. Cancer radiotherapie, 24 (8) pp. 866-869. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_13E546BAAD65]
 
An imbalance in competing mortality favouring Debio 1143 - Authors' reply.
Bourhis J., Sun X.S., Tao Y., 2020/11. The Lancet. Oncology, 21 (11) pp. e503. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_61679F8F2A6E]
 
Percussion assisted radiation therapy in Hodgkin lymphoma allows a marked reduction in heart dose.
Durham A.D., Lovis A., Simons J., Long O., Buela F., Ogna A., Jumeau R., Cairoli A., Rocha Do Carmo Leal S., Zeverino M. et al., 2020/11. Radiotherapy and oncology, 152 pp. 163-168. Peer-reviewed.
[DOI][Pmid][serval:BIB_3318F3D0CA17]
 
PO-0956: Neuroendocrine Tumors of the Breast: an international series of the Rare Cancer Network
Grellier-Adedjouma N., Paix A., Franco P., Kirova Y.M., De Bari B., Pasquier D., Meijer H., Oksüz D.C., Peignaux-Casasnovas K., Huguet F. et al., 2020/11., ESTRO 2020 - Online Congress, 28 November to 1 December 2020 pp. S510-S511 dans Radiotherapy and Oncology. Peer-reviewed.
[DOI][serval:BIB_131F757D31E7]
 
Flap delineation guidelines in postoperative head and neck radiation therapy for head and neck cancers.
Le Guevelou J., Bastit V., Marcy P.Y., Lasne-Cardon A., Guzene L., Gerard M., Larnaudie A., Coutte A., Beddok A., Calugaru V. et al., 2020/10. Radiotherapy and oncology, 151 pp. 256-265. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_120ED9D8B252]
High versus low dose irradiation for tumor immune reprogramming.
de Olza M.O., Bourhis J., Irving M., Coukos G., Herrera F.G., 2020/10. Current opinion in biotechnology, 65 pp. 268-283. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_330632946BBD]
Retrospective analysis of the impact of respiratory motion in treatment margins for frameless lung SBRT based on respiratory-correlated CBCT data-sets.
Thengumpallil S., Racine D., Germond J.F., Péguret N., Bourhis J., Bochud F., Moeckli R., 2020/10. Journal of applied clinical medical physics, 21 (10) pp. 170-178. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C985E6089C8E]
 
Surgical Management and Outcomes of Rectal Cancer with Synchronous Prostate Cancer: A Multicenter Experience from the GRECCAR Group.
Doussot A., Vernerey D., Rullier E., Lefevre J.H., Meillat H., Cotte E., Piessen G., Tuech J.J., Panis Y., Mege D. et al., 2020/10. Annals of surgical oncology, 27 (11) pp. 4286-4293. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EC2EBA5D7A3C]
 
Tachycardies ventriculaires réfractaires : quelle place pour la radiothérapie et comment ? [Refractory ventricular tachycardia: Is there a role for radiotherapy?]
Jumeau R., Pruvot É., Thariat J., Latorzeff I., Milliez P.U., Champ-Rigot L., De Crevoisier R., Ferchaud V., 2020/10. Cancer radiotherapie, 24 (6-7) pp. 534-546. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_97F278C48DAA]
 
Validation interne au GORTEC du consensus international de délinéation des CTV-P pour les cancers des VADS (méthode de consensus formalisé) : résultats des phases de cotation []
Lapeyre M., Pointreau Y., Biau J., Boisselier P., Blanchard P., Graff-Cailleaud P., Huguet F., Racadot S., Alfonsi M., Castelli J. et al., 2020/10. Cancer radiotherapie, 24 (6-7) pp. 775-776. Peer-reviewed.
[DOI][Pmid][serval:BIB_8B9A10A0683C]
 
Survival of the fetus: cervical cancer and pregnancy, a challenging combination.
Levy L., Meuwly J.Y., Sarivalasis A., Achtari C., Mathevet P., Herrera F.G., 2020/09/05. Lancet, 396 (10252) p. 725. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_16AC5A00A805]
 
A delivery quality assurance tool based on the actual leaf open times in tomotherapy.
Schopfer M., Bochud F.O., Bourhis J., Moeckli R., 2020/09. Medical physics, 47 (9) pp. 3845-3851. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F8792BD6D01D]
A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives.
Achard V., Aebersold D.M., Allal A.S., Andratschke N., Baumert B.G., Beer K.T., Betz M., Breuneval T., Bodis S., de Bari B. et al., 2020/09. Radiotherapy and oncology, 150 pp. 1-3. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E516996E2A53]
 
Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial.
Tao Y., Auperin A., Blanchard P., Alfonsi M., Sun X.S., Rives M., Pointreau Y., Castelli J., Graff P., Wong Hee Kam S. et al., 2020/09. Radiotherapy and oncology, 150 pp. 18-25. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A2CE5DA53CCF]
 
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.
Sun X.S., Tao Y., Le Tourneau C., Pointreau Y., Sire C., Kaminsky M.C., Coutte A., Alfonsi M., Boisselier P., Martin L. et al., 2020/09. The Lancet. Oncology, 21 (9) pp. 1173-1187. Peer-reviewed.
[DOI][Pmid][serval:BIB_351B07FE21EC]
A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.
Biau J., Thivat E., Millardet C., Saroul N., Pham-Dang N., Molnar I., Pereira B., Durando X., Bourhis J., Lapeyre M., 2020/08/05. BMC cancer, 20 (1) p. 730. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_38F129A5884C]
A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries.
Belkacemi Y., Grellier N., Ghith S., Debbi K., Coraggio G., Bounedjar A., Samlali R., Tsoutsou P.G., Ozsahin M., Chauvet M.P. et al., 2020/08. European journal of cancer, 135 pp. 130-146. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_781F39A88B91]
 
In Regard to van Marlen et al.
Moeckli R., Germond J.F., Bailat C., Bochud F., Vozenin M.C., Bourhis J., 2020/08/01. International journal of radiation oncology, biology, physics, 107 (5) pp. 1012-1013. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6F368CA65A21]
 
Postoperative Radiation Therapy in Patients with Extracranial Chondrosarcoma: A Joint Study of the French Sarcoma Group and Rare Cancer Network.
Terlizzi M., Le Pechoux C., Salas S., Rapeaud E., Lerouge D., Sunyach M.P., Vogin G., Sole C.V., Zilli T., Lutsyk M. et al., 2020/07/15. International journal of radiation oncology, biology, physics, 107 (4) pp. 726-735. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7F8BCBDEB9CE]
 
Understanding High-Dose, Ultra-High Dose Rate, and Spatially Fractionated Radiation Therapy.
Griffin R.J., Ahmed M.M., Amendola B., Belyakov O., Bentzen S.M., Butterworth K.T., Chang S., Coleman C.N., Djonov V., Formenti S.C. et al., 2020/07/15. International journal of radiation oncology, biology, physics, 107 (4) pp. 766-778. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5B74B215D678]
Durable and controlled depletion of neutrophils in mice.
Boivin G., Faget J., Ancey P.B., Gkasti A., Mussard J., Engblom C., Pfirschke C., Contat C., Pascual J., Vazquez J. et al., 2020/06/02. Nature communications, 11 (1) p. 2762. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9A28486B8033]
 
Dose indicator for CyberKnife image-guided radiation therapy.
Moeckli R., Baillod A., Gibellieri D., Conrad M., Marsolat F., Schiappacasse L., Jumeau R., Jeanneret-Sozzi W., Bourhis J., Bochud F.O. et al., 2020/06. Medical physics, 47 (5) pp. 2309-2316. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4D803EA4BBCB]
 
Proton therapy for head and neck squamous cell carcinomas: A review of the physical and clinical challenges.
Beddok A., Vela A., Calugaru V., Tessonnier T., Kubes J., Dutheil P., Gerard A., Vidal M., Goudjil F., Florescu C. et al., 2020/06. Radiotherapy and oncology, 147 pp. 30-39. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4B01C68B7166]
 
Combining immunotherapy and radiotherapy in head and neck squamous cell cancers: which perspectives?
Biau J., Bourhis J., 2020/05. Current opinion in oncology, 32 (3) pp. 196-202. Peer-reviewed.
[DOI][Pmid][serval:BIB_0E170F81A2AC]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University